CHU de Nice
Nice, France
We are pleased to congratulate CHU de Nice on achieving IASIOS Accredited Centre status. This milestone reflects the centre’s strong commitment to patient safety and clinical quality in interventional oncology.
As interventional oncology is increasingly recognised as a core pillar of multidisciplinary cancer care, dedication to standardised practice and structured evaluation is truly commendable.
Congratulations to Prof. Chevallier and the entire interventional radiology team on this achievement. Your dedication to advancing high-quality patient care is truly appreciated.
251 Hellenic Airforce Hospital
Athens, Greece
We are pleased to announce that 251 Hellenic Air Force Hospital has achieved the status of IASIOS Accredited Centre. This accreditation confirms that the hospital’s interventional oncology patient pathway meets the core criteria defined in the CIRSE Standards of Quality Assurance in Interventional Oncology, including structured clinical processes, multidisciplinary collaboration, and procedural safety.
Our warmest congratulations go to the entire interventional radiology and oncology team for their commitment to delivering standardised, high-quality care to patients undergoing minimally invasive cancer treatments.
Ordensklinikum Linz
Linz, Austria
Ordensklinikum Linz has reached an important milestone by becoming the first facility in Austria to achieve IASIOS accreditation in interventional oncology.
Under the leadership of Dr. Alexander Kupferthaler, the centre has demonstrated compliance with international standards for quality assurance and structured patient care in interventional oncology.
This accreditation confirms that Ordensklinikum Linz meets defined benchmarks in infrastructure, multidisciplinary collaboration, procedural safety, and service organisation within the management of cancer patients.
We extend our congratulations to the entire interventional radiology and oncology team for their commitment to standardised, high-quality interventional oncology services.
Chris O Brien Lifehouse
Camperdown, Australia
We are pleased to announce that Chris O’Brien Lifehouse in Camperdown, Australia, has achieved IASIOS Accredited Centre status, becoming the second facility in the country to earn this recognition.
Under the leadership of Dr. Chris Rogan, the team has shown outstanding dedication to delivering high-quality, structured care in interventional oncology and to setting a benchmark for excellence in the region.
We congratulate the entire team on this significant achievement and welcome them to the growing network of IASIOS Accredited Centres.
Hospital da Universidade de Coimbra
Coimbra, Portugal
We are pleased to share that Hospital da Universidade de Coimbra in Portugal has been recognised as an IASIOS Accredited Centre. This achievement confirms that its interventional oncology service meets the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.
Under the leadership of Prof. Dr. Paulo Donato, the team has shown outstanding dedication to structured, patient-centred care and continuous quality improvement.
We warmly congratulate them on this accomplishment and welcome them to the expanding network of IASIOS Accredited Centres.
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy
We are delighted to announce that Fondazione Policlinico Universitario Campus Bio-Medico from Italy has become an IASIOS Accredited Centre. This confirms that the hospital’s interventional oncology service line meets the highest international standards of standardisation and quality. Under the leadership of Prof. Rosario Francesco Grasso, the team has demonstrated a strong commitment to providing safe, consistent, and patient-centred care while pursuing continuous improvement.
The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital
Amsterdam, Netherlands
We are proud to announce that The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital has achieved the status of IASIOS Accredited Centre. This achievement demonstrates that its interventional oncology service fulfils the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. Led by Dr. Tarik Baetens, the team has displayed strong dedication to delivering structured, patient-focused care and maintaining continuous quality improvement. We congratulate them on this important milestone.
Amsterdam UMC
Nijmegen, Netherlands
We are proud to share that Amsterdam UMC in the Netherlands has been recognised as an IASIOS Accredited Centre. This achievement confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.
Under the leadership of Prof. Martijn Meijerink, the team has shown a clear dedication to safety, quality, and patient-centred care in interventional oncology.
Prof. Martijn Meijerink
IASIOS Council Member
(Amsterdam University Medical Centre, Netherlands)
Charité Universitätsmedizin Berlin
Berlin, Germany
Congratulations to Charité Universitätsmedizin Berlin in Germany on becoming an IASIOS Accredited Centre. This achievement affirms that their interventional oncology service adheres to the international standards of quality and safety. Under the leadership of Prof. Dr. Bernhard Gebauer, the team has demonstrated a strong commitment to structured, patient-centered care and continuous quality improvement. We value their dedication to this milestone and look forward to their continued success within the IASIOS community.
National Institutes of Health
Bethesda, Maryland
We are pleased to announce that the National Institutes of Health (NIH) in Bethesda, Maryland, has become an IASIOS Accredited Centre.This recognition confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.
Led by Dr Brad Wood, the accreditation reflects the team’s outstanding commitment to quality, safety, and standardisation in patient care.
As a leader in medical research and healthcare, NIH sets an important example by aligning world-class expertise with internationally standardised pathways in interventional oncology.
We extend our warmest congratulations to Dr Wood and the entire team for this outstanding achievement.